PARIS (Reuters) – The French state has told drugmaker Servier it was against any sale of its generics subsidiary Biogaran, which has a market share of almost a third in France, French Prime Ministers Gabriel Attal told lawmakers on Wednesday.
French media reported last month that Servier had asked potential suitors to file their offers by mid-June.
(Reporting by Benoit Van Overstraeten; Editing by Tassilo Hummel)
Comments